Current clinical management of constitutional delay of growth and puberty

被引:8
|
作者
Gaudino, Rossella [1 ]
De Filippo, Gianpaolo [2 ,3 ]
Bozzola, Elena [4 ]
Gasparri, Manuela [5 ]
Bozzola, Mauro [6 ]
Villani, Alberto [4 ]
Radetti, Giorgio [7 ]
机构
[1] Univ Verona, Dept Surg Sci Dent Gynecol & Pediat, Pediat Div, Verona, Italy
[2] Hop Robert Debre, AP HP, Serv Endocrinol & Diabetol Pediat, Paris, France
[3] French Clin Res Grp Adolescent Med & Hlth, Paris, France
[4] IRCCS Bambino Gesu Children Hosp, Pediat Unit, Rome, Italy
[5] San Paolo Hosp, Dept Pediat, Milan, Italy
[6] Univ Pavia, Pavia, Italy
[7] Prov Autonoma Bolzano, Bolzano, Italy
关键词
Puberty; Delayed puberty; Bone age; Growth; Constitutional delay of growth and puberty; Hypogonadotropic hypogonadism; PATTERN;
D O I
10.1186/s13052-022-01242-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Constitutional delay of growth and puberty (CDGP) is classified as the most frequent cause of delayed puberty (DP). Finding out the etiology of DP during first evaluation may be a challenge. In details, pediatricians often cannot differentiate CDGP from permanent hypogonadotropic hypogonadism (PHH), with definitive diagnosis of PHH awaiting lack of puberty by age 18 yr. Neverthless, the ability in providing a precise and tempestive diagnosis has important clinical consequences. Main text: A growth failure in adolescents with CDGP may occur until the onset of puberty; after that the growth rate increases with rapidity. Bone age is typically delayed. CDGP is generally a diagnosis of exclusion. Nevertheless, other causes of DP must be evaluated. A family history including timing of puberty in the mother and in the father as well as physical examination may givee information on the cause of DP. Patients with transient delay in hypothalamicpituitary- gonadal axis maturation due to associated conditions, such as celiac disease, inflammatory bowel diseases, kidney insufficiency and anorexia nervosa, may experience a functional hypogonadotropic hypogonadism. PHH revealing testosterone or estradiol low serum values and reduced FSH and LH levels may be connected to abnormalities in the central nervous system. So, magnetic resonance imaging is required in order to exclude either morphological alterations or neoplasia. If the adolescent with CDGP meets psychological difficulties, treatment is recommended. Conclusion: Even if CDGP is considered a variant of normal growth rather than a disease, short stature and retarded sexual development may led to psychological problems, sometimes associated to a poor academic performance. A prompt and precise diagnosis has an important clinical outcome. Aim of this mini-review is throwing light on management of patients with CDGP, emphasizing the adolescent diagnosis and trying to answer all questions from paediatricians.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Prevalence of Deleterious Variants in MC3R in Patients With Constitutional Delay of Growth and Puberty
    Duckett, Katie
    Williamson, Alice
    Kincaid, John W. R.
    Rainbow, Kara
    Corbin, Laura J.
    Martin, Hilary C.
    Eberhardt, Ruth Y.
    Huang, Qin Qin
    Hurles, Matthew E.
    He, Wen
    Brauner, Raja
    Delaney, Angela
    Dunkel, Leo
    Grinspon, Romina P.
    Hall, Janet E.
    Hirschhorn, Joel N.
    Howard, Sasha R.
    Latronico, Ana C.
    Jorge, Alexander A. L.
    McElreavey, Ken
    Mericq, Veronica
    Merino, Paulina M.
    Palmert, Mark R.
    Plummer, Lacey
    Rey, Rodolfo A.
    Rezende, Raissa C.
    Seminara, Stephanie B.
    Salnikov, Kathryn
    Banerjee, Indraneel
    Lam, Brian Y. H.
    Perry, John R. B.
    Timpson, Nicholas J.
    Clayton, Peter
    Chan, Yee-Ming
    Ong, Ken K.
    O'Rahilly, Stephen
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (12): : E1570 - E1577
  • [32] Adolescent boys with constitutional delay of growth and puberty grow faster than patients with organic growth hormone deficiency
    Binder, Gerhard
    Lehrian, Theresa J.
    Hoffmann, Elisa
    Blumenstock, Gunnar
    Rahmaoui, Abdelkader
    Trzaskoma, Benjamin
    Reinehr, Thomas
    CLINICAL ENDOCRINOLOGY, 2021, 94 (02) : 237 - 241
  • [34] Boosting the Late-Blooming Boy: Use of Growth-Promoting Agents in the Athlete With Constitutional Delay of Growth and Puberty
    Curtis, Vanessa A.
    Allen, David B.
    SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH, 2011, 3 (01): : 32 - 40
  • [35] Final height outcome in both untreated and testosterone-treated boys with constitutional delay of growth and puberty
    Arrigo, T
    Cisternino, M
    DeLuca, F
    Saggese, G
    Messina, MF
    Pasquino, AM
    DeSanctis, V
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 1996, 9 (05): : 511 - 517
  • [36] Congenital hypogonadotropic hypogonadism, functional hypogonadotropism or constitutional delay of growth and puberty? An analysis of a large patient series from a single tertiary center
    Varimo, Tero
    Miettinen, Paivi J.
    Kansakoski, Johanna
    Raivio, Taneli
    Hero, Matti
    HUMAN REPRODUCTION, 2017, 32 (01) : 147 - 153
  • [37] Growth Velocity in Constitutional Delay of Growth and Development
    Butenandt, Otfrid
    Kunze, Detlef
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2010, 23 (1-2): : 19 - 25
  • [38] Is neuropeptide Y responsible for constitutional delay of puberty in girls?: A preliminary report
    Blogowska, A
    Rzepka-Górska, I
    Krzyzanowska-Swiniarska, B
    GYNECOLOGICAL ENDOCRINOLOGY, 2004, 19 (01) : 22 - 25
  • [39] Constitutional delay of puberty: presentation and inheritance pattern in 48 familial cases
    Winter, Sarah
    Ousidhoum, Aldjia
    McElreavey, Kenneth
    Brauner, Raja
    BMC PEDIATRICS, 2016, 16
  • [40] Leuteinizing hormone responses to leuprolide acetate discriminate between hypogonadotropic hypogonadism and constitutional delay of puberty
    Street, ME
    Bandello, MA
    Terzi, C
    Ibañez, L
    Ghizzoni, L
    Volta, C
    Tripodi, C
    Virdis, R
    FERTILITY AND STERILITY, 2002, 77 (03) : 555 - 560